Multimorbidity
Conditions
Interventions
Group 1: A Medication Management for residents of nursing homes will be performed by pharmacists in collaboration with physicians and nurses by means of an innovative algorithm. There is no control gr
Sponsors
Elefanten-Apotheke
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: Residency in a nursing home facility, multimorbidity (at least 2 chronic diseases), polymedication (at least 5 chronic systemic available medications), signed informed consent
Exclusion criteria
Exclusion criteria: participation in other clinical studies at present time
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the reduction of the detected drug-related problems (DRPs), using the algorithm. DRPs are measured at time of the Medication Review (t0) and classified according PCNE (Pharmaceutical Care Network Europe) version 8.01. A follow-up is performed three month after the intervention (t1). | — |
Secondary
| Measure | Time frame |
|---|---|
| - Drug-related problems classified according to PCNE version 8.01 (number and type) - Measurement of physicians’ and nurses’ acceptance by using an acceptance form, classified according to PCNE version 8.01 - Number of drug-related problems classified according to PCNE version 8.01, detected by an Advanced Medication Review - Reproducibility of analysis and feasibility of the algorithm (feedback survey, time spending, inter-rater reliability) | — |
Countries
Germany
Contacts
Public ContactSusanne Erzkamp
Elefanten-Apotheke
Outcome results
None listed